Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Comparison of Ketamine 0.1 mg/kg, 0.2 mg/kg, and 0.3 mg/kg Intravenous Doses for Acute Pain in the Emergency Department: A Prospective, Randomized, Double-blind, Active-controlled, Clinical Trial

To see complete record on, please visit this link

Id: NCT03896230

Organisation Name: Hackensack Meridian Health

Overal Status: Suspended

Start Date: May 3, 2019

Last Update: September 6, 2022

Lead Sponsor: Hackensack Meridian Health

Brief Summary: This study will prospectively compare the mean Numerical Rating Scale (NRS) pain score reduction amongst three recommended dosing strategies of intravenous ketamine (0.1 mg/kg, 0.2 mg/kg, and 0.3mg/kg) for acute pain in the emergency department (ED).This study will also examine the frequency of adverse events secondary to ketamine including fatigue, dizziness, nausea, headache, feeling of unreality, changes in hearing or vision, mood changes, generalized discomfort, and hallucinations, changes in vital signs. Subgroups for exploratory analysis based on the need for rescue analgesia within two hours of ketamine administration, adequate pain relief, previous opioid tolerance, and age (adults < 65 years old and > 65 years old).

  • Acute Pain

Total execution time in seconds: 1.4285399913788